Anzeige
Mehr »
Login
Freitag, 24.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Hinter dem nuklearen Ansturm im Silicon Valley: Eine strategische Chance entsteht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EVGP | ISIN: US89237H3084 | Ticker-Symbol: N/A
Berlin
02.07.24
08:26 Uhr
1,410 Euro
0,000
0,00 %
1-Jahres-Chart  (nicht börsennotiert)
TRACON PHARMACEUTICALS INC Chart 1 Jahr

Aktuelle News zur TRACON PHARMACEUTICALS

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
07.11.24Tracon Pharmaceuticals, Inc. - 15-12G, Securities registration termination2
14.10.24Tracon Pharmaceuticals issues super-voting share to CEO5
14.10.24Tracon Pharmaceuticals gibt Super-Stimmrechtsaktie an CEO aus2
11.10.24Tracon Pharmaceuticals, Inc. - 8-K, Current Report1
13.08.24Tracon Pharmaceuticals, Inc. - 10-Q, Quarterly Report3
31.07.24Tracon Pharmaceuticals winds down weeks after world's first injectable PD-L1 inhibitor stumbles in phase 211
30.07.24TRACON Pharmaceuticals to wind down operations4
TRACON PHARMACEUTICALS Aktie jetzt für 0€ handeln
30.07.24Tracon Pharmaceuticals, Inc. - 8-K, Current Report-
30.07.24TRACON Pharmaceuticals, Inc.: TRACON Pharmaceuticals Announces it Will Wind Down Operations227SAN DIEGO, July 30, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (OTCQB: TCON) today announced that the Company has terminated its employees and will wind down its operations. This decision was...
► Artikel lesen
16.07.24Delisting of Securities of CONX Corp.; Priveterra Acquisition Corp. II; Yield10 Bioscience, Inc.; Aesthetic Medical International Holdings Group; Breeze Holdings Acquisition Corp.; Quadro Acquisition One Corp.; DermTech, Inc.; TRACON Pharmaceuticals ...264NEW YORK, July 16, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock, units, and warrants of CONX Corp. CONX Corp.'s securities were suspended on...
► Artikel lesen
01.07.24TRACON Pharmaceuticals, Inc.: TRACON Pharmaceuticals Announces Termination of ENVASARC Trial and Will Explore Strategic Alternatives Leveraging its In-House Product Development Platform157The objective response rate by blinded independent central review in the fully enrolled ENVASARC pivotal trial in the 82 evaluable patients is 5% (four responders) and did not meet the primary endpoint...
► Artikel lesen
11.06.24TRACON Pharmaceuticals, Inc.: TRACON Announces Publication in Clinical Cancer Research of Phase 2 Clinical Data for TRC102, a DNA Damage Repair Inhibitor, in Recurrent Glioblastoma Patients172Publication Highlights Activity of the Combination of TRC102 and Temodar (Temozolomide) in Patients who Progressed Following Initial Treatment with Surgical Resection, Temodar and External Beam Radiotherapy...
► Artikel lesen
14.05.24TRACON Pharmaceuticals, Inc.: TRACON Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update172SAN DIEGO, May 14, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development...
► Artikel lesen
08.04.24TRACON Pharmaceuticals, Inc.: TRACON Pharmaceuticals Announces Reverse Stock Split340SAN DIEGO, April 08, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent Product Development Platform...
► Artikel lesen
05.03.24TRACON Pharmaceuticals, Inc.: TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update218SAN DIEGO, March 05, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development...
► Artikel lesen
15 Nachrichten in den letzten 12 Monaten